Insider Trading – How to benefit from the information?


The Indian stock market has gone through a tremendous re-rating and turmoil. Stock prices have nosedived and the pandemic has only made it worse.

In times like these, what would you make if promoters were buying their own stocks? The naysayers would look at it and say that the promoters were only trying to shore up their own stock prices. However, prudent investors would look at this as an opportunity for buying as promoters themselves feel that their stock is undervalued.

What if you had access to this buying or selling by the people in the know? Wouldn’t it signal an opportunity to buy or sell? Wouldn’t it be great to have a tool which could collate all this information and give it to you at one place?

Introducing the Insider trading tool from StockArchitect. This tool gleans through the different filings of promoters with the exchanges and also from different sources to arrive at a structured output for the stocks in which promoters have bought or sold. It displays the trends over the last 3 months, 6 months and 1 year.

Users can click on the name of the stock to get a detailed analysis of the trades that have taken place. Users also have the choice to click on the name of the promoter / investor / company and look at all deals executed by that individual / entity.

The data is updated on a real-time basis, as and when it is submitted to the exchanges.

We also have Stocks on the Radar – This is a list of stocks detected by Artificial Intelligence based algorithm where genuine buying from the promoters is happening.

The information is by no means a recommendation to buy or sell and should not be treated that way. Users are advised to make informed decisions and consult their financial advisors before making any investment decision. StockArchitect is not responsible for any gains or losses made by the users of the website in any manner.

The Insider Trading Tool is available for a small fee which is less than what one spends on one cup of tea. And there is a free 7 day trial period as well.

Visit https://stockarchitect.com/tools/insider_trading now and avail of the benefits.


Reblog: The gray art of not quite insider trading


Scores of arrests and the indictment of SAC Capital have Wall Street spooked. But what’s the crime exactly? The SEC and the Supreme Court disagree. So nobody’s sure — and that’s how regulators like it. 

“We used to be able to talk to investigators on drug trials,” says Source A, a hedge fund portfolio manager. Like all the analysts, research directors, and portfolio managers who cooperated for this article, Source A requested anonymity. People don’t want their names in a story about gray areas of equities research that border on insider trading.

Four or five years ago, Source A continues, he and other health care analysts still used to get in touch with doctors who were serving as investigators in Phase II or Phase III trials, studies required by the U.S. Food and Drug Administration before a pharmaceutical can be approved as safe and effective. He might have been able to reach as many as eight out of 10 investigators running a study, and sometimes he could reach the principal investigator, the overseer of the whole thing.

“Say each investigator has 11 patients,” Source A continues. “You could almost go patient by patient,” asking how they were doing.

Continue Reading